|Study Period:||2018- 2026|
|Fastest Growing Market:||Asia Pacific|
|Largest Market:||North America|
Need a report that reflects how COVID-19 has impacted this market and its growth?
The cold plasma in healthcare market is expected to register a CAGR of 12.5% during the forecast period, 2021-2026. The market is expected to show good growth due to the benefits associated with cold plasma techniques and the increasing use of cold plasma in wound healing.
With the rising number of COVID-19 patients, plasma therapy has shown positive results for coronavirus treatment. Cold plasma treatment is also being touted as an effective remedy against the ongoing COVID-19 pandemic. The demand for plasma therapy is increasing due to its potential use in coronavirus treatment. The United States, China, Turkey, Spain, and the United Kingdom are few countries that are also looking at plasma therapy to more easily address the worldwide COVID-19 crisis. Even in India, it was found that in Delhi, a hospital has successfully cured a COVID-19 patient using plasma therapy. The patients were found with increased respiratory rate and oxygen saturation level.
The field of cold plasma in medicine is thus growing quickly as cold plasma has the ability to kill bacteria and prevent infections, and it has been proven to be successful in treating burns.
According to the Canadian Cancer Society, an estimated 27,400 women were diagnosed with breast cancer in the country in 2020. This represents 25% of all new cancer cases in women by 2020, with 5,100 women dying from breast cancer. Gas plasmas or ionized gases have many developing applications in cancer treatment, and hence, as the cancer cases increase, the market is likely to grow shortly.
Also, cold plasma is effectively combined with chemotherapy in cancer treatment and promotes wound sterilization, blood coagulation, and cell proliferation in wound healing. Its use allows for effective medical treatment of cancer and various skin injuries and diseases.
It has also been found that recently, cold plasma was also used in Germany in limited preliminary trials as palliative therapy for head and neck cancer patients. Therefore, the rising applications of cold plasma in wound healing, cancer treatment, and infective diseases are augmenting the growth of the market studied.
Scope of the Report
As per the scope of the report, cold plasma is an ionized gas at room temperature that is created by electric discharge. Cold plasma treatment is a contact-free and painless procedure to sterilize wounds and promote wound healing. The costs are comparable to or lower than those of standard antimicrobial wound treatment. The cold plasma in healthcare market is segmented by application (wound healing, blood coagulation, dentistry, cancer treatment, and other medical applications), regime (low-pressure cold plasma and atmospheric cold plasma), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.
|Other Medical Applications|
|Low-pressure Cold Plasma|
|Atmospheric Cold Plasma|
Key Market Trends
The Wound Healing Segment is Expected to Hold a Significant Market Share
The wound healing segment is expected to hold a high market share as cold plasma has the ability to kill bacteria, including drug-resistant bacteria, to prevent further infection rate and thus helps in treating chronic wounds. It is also found to boost the wound healing process and eliminates further complications.
With the rising COVID-19, the demand for cold plasma is found to increase. The basis for this development is provided by Plasma Care that is a CE-mark approved medical device that generates cold atmospheric plasma that was found to be developed for the mobile treatment of acute and chronic wounds.
According to the World Health Organization 2020, there are more than 1.35 million people that die every year as a result of road traffic crashes and accidents. Road traffic injuries are the leading cause of death among people aged between 15 and 29 years. Every year, the lives of more than 1.35 million people are cut short as a result of road traffic crashes. Therefore, since there are a large number of trauma and wound management cases observed yearly, the adoption rate of cold plasma is expected to be high for wound healing across hospitals and healthcare facilities.
Moreover, as per the Germany Federal Statistical Office 2020 report, currently, there are about 83 million people in Germany, of which 16.2 million people are above 67 years of age, and it is projected to reach 21.4 million by 2040. With the increase in the geriatric population, there is an increasing diabetic population, which results in chronic wounds such as foot ulcers and thus boosts the overall market.
Although many other treatment procedures are present for wound healing, cold plasma treatment is anticipated to be one of the effective ways that drive the overall segment further.
To understand key trends, Download Sample Report
North America is Expected to Hold a Significant Share in the Market and is Expected to do the Same in the Forecast Period
North America dominates the cold plasma market owing to the presence of key industry participants and the availability of various FDA-approved products. There has been a rising adoption of technologically advanced products that also fuel the market growth.
With the rising COVID-19, the demand for plasma therapy is found increasing. Based on the recent 2020 study, UCLA engineers and scientists have demonstrated that treatments with near-room-temperature, cold atmospheric plasma can kill the coronavirus present on a variety of surfaces. The study published in the journal Physics of Fluids marks the first time cold plasma has been shown to effectively and quickly disinfect surfaces contaminated with the SARS-CoV-2 virus that causes COVID-19. The potential of cold atmospheric plasma is a safe and effective way to fight the transmission of the virus by killing it on a wide range of surfaces.
According to Breast Cancer.org statistics, breast cancer most commonly occurs among women in North America. As of January 2020, around 3.5 million women have a history of breast cancer in the United States. Also, breast cancer is the most diagnosed cancer among women in the United States. It is also estimated that around 30% of newly diagnosed cancers in women are breast cancers. In addition to the source mentioned above, an estimated 276,480 cases of invasive breast cancer and approximately 48,530 new carcinoma cases in situ (CIS) are expected to be diagnosed in 2020. Moreover, the average risk of a woman in the United States developing breast cancer in her life is about 13%. Therefore, with the increasing prevalence of cancer and chronic wounds, the market is expected to grow.
In addition, the Asia-Pacific market is expected to register high growth primarily due to the growing demand for cold plasma technology and a majority of global companies focusing on developing and expanding their R&D capabilities and distribution networks in this region. Rise in disposable income levels and the growing target population base are also likely to contribute to the overall market growth.
To understand geography trends, Download Sample Report
The cold plasma in the healthcare market is consolidated competitive. Some of the key companies in the cold plasma market are U.S. Medical Innovations LLC, Bovie Medical Corporation, Neoplas Tools GmbH, Europlasma NV, and P2i Limited. The key players involved in market expansion analyze competitive developments (such as partnerships, agreements, collaborations, alliances, mergers and acquisitions, new product developments, geographical expansions, and R&D activities) and strategically and comprehensively analyze their core competencies in the cold plasma market.
In February 2020, Henniker Plasma signed a partnership with Irida (Spain), which helped the company to strengthen its geographic presence in Spain.
In February 2020, Adtech Plasma Technology initiated a new project in collaboration with Hull York Medical School for testing gas plasma on osteomyelitis bone infections. The project will assist in establishing a laboratory testing model for evaluating and optimizing plasma treatment for osteomyelitis biofilm infections.
Table of Contents
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Environment Friendliness and Other Benefits of Cold Plasma Techniques
4.2.2 Increasing Use of Cold Plasma in Wound Healing
4.3 Market Restraints
4.3.1 Lack of Awareness about Cold Plasma Technology in the Healthcare Industry
4.3.2 Stringent Regulatory Policies
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Application
5.1.1 Wound Healing
5.1.2 Blood Coagulation
5.1.4 Cancer Treatment
5.1.5 Other Medical Applications
5.2 By Regime
5.2.1 Low-pressure Cold Plasma
5.2.2 Atmospheric Cold Plasma
5.3.1 North America
220.127.116.11 United States
18.104.22.168 United Kingdom
22.214.171.124 Rest of Europe
126.96.36.199 South Korea
188.8.131.52 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
184.108.40.206 South Africa
220.127.116.11 Rest of Middle-East and Africa
5.3.5 South America
18.104.22.168 Rest of South America
6. COMPETITIVE LANDSCAPE
*List Not Exhaustive
6.1 Company Profiles
6.1.1 ADTEC Plasma Technology Co. Ltd
6.1.2 Wacker Chemie AG
6.1.3 Europlasma NV
6.1.4 Neoplas med GmbH
6.1.5 Nordson Corporation
6.1.6 P2I Limited
6.1.7 Plasmatreat GmbH
6.1.8 Tantec AS
6.1.9 U.S. Medical Innovations
6.1.10 Enercon Industries Corporation
6.1.11 terraplasma medical GmbH
6.1.12 VETAPHONE AS
6.1.13 TOMI Environmental Solutions Inc.
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Global Cold Plasma in Healthcare Market market is studied from 2018 - 2026.
What is the growth rate of Global Cold Plasma in Healthcare Market?
The Global Cold Plasma in Healthcare Market is growing at a CAGR of 12.5% over the next 5 years.
Which region has highest growth rate in Global Cold Plasma in Healthcare Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Global Cold Plasma in Healthcare Market?
North America holds highest share in 2020.
Who are the key players in Global Cold Plasma in Healthcare Market?
Wacker Chemie AG, ADTEC Plasma Technology Co. Ltd., Neoplas med GmbH, U.S. Medical Innovations, terraplasma medical GmbH are the major companies operating in Global Cold Plasma in Healthcare Market.